Gamazyme DPC
Gamazyme DPC
Other means of
7613-64, 587055
identification
1.2. Relevant identified uses of the substance or mixture and uses advised against
Relevant identified
Use according to manufacturer's directions.
uses
Uses advised against Not Applicable
regulation (EC) No
[1]
1272/2008 [CLP]
1. Classified by Chemwatch; 2. Classification drawn from EC Directive 67/548/EEC - Annex I ; 3. Classification drawn from EC
Legend:
Directive 1272/2008 - Annex VI
Hazard statement(s)
H318 Causes serious eye damage.
Supplementary statement(s)
Not Applicable
IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue
P305+P351+P338
rinsing.
REACh - Art.57-59: The mixture does not contain Substances of Very High Concern (SVHC) at the SDS print date.
3.1.Substances
See 'Composition on ingredients' in Section 3.2
3.2.Mixtures
1.CAS No
2.EC No
%[weight] Name Classification according to regulation (EC) No 1272/2008 [CLP]
3.Index No
4.REACH No
1.9014-01-1
Specific target organ toxicity - single exposure Category 3 (respiratory tract irritation), Skin
2.232-752-2
1-5 subtilisins Corrosion/Irritation Category 2, Serious Eye Damage Category 1, Respiratory Sensitizer
3.647-012-00-8 [3]
Category 1; H335, H315, H318, H334
4.01-2119480434-38-XXXX
Legend: 1. Classified by Chemwatch; 2. Classification drawn from EC Directive 67/548/EEC - Annex I ; 3. Classification drawn from EC
Directive 1272/2008 - Annex VI 4. Classification drawn from C&L
If fumes, aerosols or combustion products are inhaled remove from contaminated area.
Inhalation
Other measures are usually unnecessary.
4.2 Most important symptoms and effects, both acute and delayed
See Section 11
4.3. Indication of any immediate medical attention and special treatment needed
Treat symptomatically.
Moderate hazard.
Major Spills
CAUTION: Advise personnel in area.
Storage
None known
incompatibility
+ X + O + + +
INGREDIENT DATA
EMERGENCY LIMITS
MATERIAL DATA
for subtilisins:
The TLV-TWA is thought to be sufficiently low to minimise the potential for allergic respiratory sensitisation for the majority of normotypic persons. It is
also expected that the TLV will minimise skin irritation and sensitisation.
Catalogue number: 7613-64 Page 5 of 12 Issue Date: 06/16/2024
Version No: 1.1 Print Date: 08/02/2024
GAMAZYME DPC
8.2.2. Personal
protection
NOTE:
The material may produce skin sensitisation in predisposed individuals. Care must be taken, when removing gloves and
other protective equipment, to avoid all possible skin contact.
The selection of suitable gloves does not only depend on the material, but also on further marks of quality which vary from
Hands/feet protection manufacturer to manufacturer. Where the chemical is a preparation of several substances, the resistance of the glove
material can not be calculated in advance and has therefore to be checked prior to the application.
Experience indicates that the following polymers are suitable as glove materials for protection against undissolved, dry
solids, where abrasive particles are not present.
polychloroprene.
Respiratory protection
Particulate. (AS/NZS 1716 & 1715, EN 143:000 & 149:001, ANSI Z88 or national equivalent)
Required Minimum Protection Factor Half-Face Respirator Full-Face Respirator Powered Air Respirator
P1 - PAPR-P1
up to 10 x ES
Air-line* - -
up to 50 x ES Air-line** P2 PAPR-P2
up to 100 x ES - P3 -
Air-line* -
100+ x ES - Air-line** PAPR-P3
Respirators may be necessary when engineering and administrative controls do not adequately prevent exposures.
The decision to use respiratory protection should be based on professional judgment that takes into account toxicity information, exposure measurement
data, and frequency and likelihood of the worker's exposure - ensure users are not subject to high thermal loads which may result in heat stress or
distress due to personal protective equipment (powered, positive flow, full face apparatus may be an option).
Published occupational exposure limits, where they exist, will assist in determining the adequacy of the selected respiratory protection. These may be
government mandated or vendor recommended.
Certified respirators will be useful for protecting workers from inhalation of particulates when properly selected and fit tested as part of a complete
respiratory protection program.
Use approved positive flow mask if significant quantities of dust becomes airborne.
Try to avoid creating dust conditions.
Relative density
Physical state Divided Solid Not Available
(Water = 1)
Catalogue number: 7613-64 Page 6 of 12 Issue Date: 06/16/2024
Version No: 1.1 Print Date: 08/02/2024
GAMAZYME DPC
Partition coefficient
Odour Not Available Not Available
n-octanol / water
Auto-ignition
Odour threshold Not Available Not Available
temperature (°C)
Decomposition
pH (as supplied) Not Available Not Available
temperature
Melting point /
Not Applicable Viscosity (cSt) Not Available
freezing point (°C)
Solubility in water
Miscible pH as a solution (1%) Not Available
(g/L)
Vapour density (Air =
Not Available VOC g/L Not Available
1)
10.3. Possibility of
See section 7.2
hazardous reactions
10.4. Conditions to
See section 7.2
avoid
10.5. Incompatible
See section 7.2
materials
10.6. Hazardous
decomposition See section 5.3
products
The material has NOT been classified by EC Directives or other classification systems as "harmful by ingestion". This is
Ingestion
because of the lack of corroborating animal or human evidence.
Skin contact is not thought to have harmful health effects (as classified under EC Directives); the material may still produce
health damage following entry through wounds, lesions or abrasions.
Limited evidence exists, or practical experience predicts, that the material either produces inflammation of the skin in a
Skin Contact substantial number of individuals following direct contact, and/or produces significant inflammation when applied to the
healthy intact skin of animals, for up to four hours, such inflammation being present twenty-four hours or more after the end
of the exposure period. Skin irritation may also be present after prolonged or repeated exposure; this may result in a form of
contact dermatitis (nonallergic).
Catalogue number: 7613-64 Page 7 of 12 Issue Date: 06/16/2024
Version No: 1.1 Print Date: 08/02/2024
GAMAZYME DPC
Open cuts, abraded or irritated skin should not be exposed to this material
Entry into the blood-stream through, for example, cuts, abrasions, puncture wounds or lesions, may produce systemic injury
with harmful effects. Examine the skin prior to the use of the material and ensure that any external damage is suitably
protected.
When applied to the eye(s) of animals, the material produces severe ocular lesions which are present twenty-four hours or
Eye
more after instillation.
Practical evidence shows that inhalation of the material is capable of inducing a sensitisation reaction in a substantial number
of individuals at a greater frequency than would be expected from the response of a normal population.
Pulmonary sensitisation, resulting in hyperactive airway dysfunction and pulmonary allergy may be accompanied by fatigue,
malaise and aching.
Practical experience shows that skin contact with the material is capable either of inducing a sensitisation reaction in a
substantial number of individuals, and/or of producing a positive response in experimental animals.
Chronic
Long term exposure to high dust concentrations may cause changes in lung function (i.e. pneumoconiosis) caused by
particles less than 0.5 micron penetrating and remaining in the lung. A prime symptom is breathlessness.
There is a possibility that unintended contact with this product (such as through a cut, needle stick, eye or mucous
membrane, or inhalation) could result in allergic or hypersensitivity reactions. Such reactions are more likely following
repeated exposures or in persons with a pre-existing allergy to certain proteins.
TOXICITY IRRITATION
GAMAZYME DPC
Not Available Not Available
TOXICITY IRRITATION
[2] Eye (rabbit): 3 mg moderate
subtilisins Oral (rat) LD50: 3700 mg/kg
Legend: 1. Value obtained from Europe ECHA Registered Substances - Acute toxicity 2.* Value obtained from manufacturer's SDS.
Unless otherwise specified data extracted from RTECS - Register of Toxic Effect of chemical Substances
The following information refers to contact allergens as a group and may not be specific to this product.
Contact allergies quickly manifest themselves as contact eczema, more rarely as urticaria or Quincke's oedema. The
pathogenesis of contact eczema involves a cell-mediated (T lymphocytes) immune reaction of the delayed type. Other
allergic skin reactions, e.g. contact urticaria, involve antibody-mediated immune reactions. The significance of the contact
GAMAZYME DPC
allergen is not simply determined by its sensitisation potential: the distribution of the substance and the opportunities for
contact with it are equally important. A weakly sensitising substance which is widely distributed can be a more important
allergen than one with stronger sensitising potential with which few individuals come into contact. From a clinical point of view,
substances are noteworthy if they produce an allergic test reaction in more than 1% of the persons tested.
Asthma-like symptoms may continue for months or even years after exposure to the material ceases. This may be due to a
non-allergenic condition known as reactive airways dysfunction syndrome (RADS) which can occur following exposure to high
levels of highly irritating compound. Key criteria for the diagnosis of RADS include the absence of preceding respiratory
disease, in a non-atopic individual, with abrupt onset of persistent asthma-like symptoms within minutes to hours of a
documented exposure to the irritant. A reversible airflow pattern, on spirometry, with the presence of moderate to severe
bronchial hyperreactivity on methacholine challenge testing and the lack of minimal lymphocytic inflammation, without
eosinophilia, have also been included in the criteria for diagnosis of RADS. RADS (or asthma) following an irritating inhalation
SUBTILISINS
is an infrequent disorder with rates related to the concentration of and duration of exposure to the irritating substance.
Industrial bronchitis, on the other hand, is a disorder that occurs as result of exposure due to high concentrations of irritating
substance (often particulate in nature) and is completely reversible after exposure ceases. The disorder is characterised by
dyspnea, cough and mucus production.
The material may produce severe irritation to the eye causing pronounced inflammation. Repeated or prolonged exposure to
irritants may produce conjunctivitis.
as CAS RN 9014-01-1
Allergic reactions which develop in the respiratory passages as bronchial asthma or rhinoconjunctivitis, are mostly the result
of reactions of the allergen with specific antibodies of the IgE class and belong in their reaction rates to the manifestation of
the immediate type. In addition to the allergen-specific potential for causing respiratory sensitisation, the amount of the
GAMAZYME DPC &
allergen, the exposure period and the genetically determined disposition of the exposed person are likely to be decisive.
SUBTILISINS
Factors which increase the sensitivity of the mucosa may play a role in predisposing a person to allergy. They may be
genetically determined or acquired, for example, during infections or exposure to irritant substances. Immunologically the low
molecular weight substances become complete allergens in the organism either by binding to peptides or proteins (haptens) or
after metabolism (prohaptens).
GAMAZYME DPC & Particular attention is drawn to so-called atopic diathesis which is characterised by an increased susceptibility to allergic
SUBTILISINS rhinitis, allergic bronchial asthma and atopic eczema (neurodermatitis) which is associated with increased IgE synthesis.
Exogenous allergic alveolitis is induced essentially by allergen specific immune-complexes of the IgG type; cell-mediated
GAMAZYME DPC &
reactions (T lymphocytes) may be involved. Such allergy is of the delayed type with onset up to four hours following
SUBTILISINS
exposure.
Catalogue number: 7613-64 Page 8 of 12 Issue Date: 06/16/2024
Version No: 1.1 Print Date: 08/02/2024
GAMAZYME DPC
Legend: – Data available but does not fill the criteria for classification
– Data required to make classification available
– Data Not Available to make classification
12.1. Toxicity
Ingredient Endpoint Test Duration (hr) Species Value Source
Extracted from 1. IUCLID Toxicity Data 2. Europe ECHA Registered Substances - Ecotoxicological Information - Aquatic Toxicity
3. EPIWIN Suite V3.12 - Aquatic Toxicity Data (Estimated) 4. US EPA, Ecotox database - Aquatic Toxicity Data 5. ECETOC
Legend:
Aquatic Hazard Assessment Data 6. NITE (Japan) - Bioconcentration Data 7. METI (Japan) - Bioconcentration Data 8. Vendor
Data
DO NOT allow wash water from cleaning or process equipment to enter drains.
It may be necessary to collect all wash water for treatment before disposal.
Recycle wherever possible or consult manufacturer for recycling options.
Consult State Land Waste Management Authority for disposal.
Waste treatment
Not Available
options
Sewage disposal
Not Available
options
Labels Required
Marine Pollutant NO
14.2.UN proper
Not Applicable
shipping name
14.5.Environmental
Not Applicable
hazard
Air transport (ICAO-IATA / DGR): NOT REGULATED FOR TRANSPORT OF DANGEROUS GOODS
14.1. UN number Not Applicable
14.2. UN proper
Not Applicable
shipping name
14.5. Environmental
Not Applicable
hazard
Sea transport (IMDG-Code / GGVSee): NOT REGULATED FOR TRANSPORT OF DANGEROUS GOODS
14.1. UN number Not Applicable
14.2. UN proper
Not Applicable
shipping name
14.5. Environmental
Not Applicable
hazard
Inland waterways transport (ADN): NOT REGULATED FOR TRANSPORT OF DANGEROUS GOODS
14.1. UN number Not Applicable
14.2. UN proper
Not Applicable
shipping name
14.3. Transport hazard
Not Applicable Not Applicable
class(es)
14.4. Packing group Not Applicable
14.5. Environmental
Not Applicable
hazard
15.1. Safety, health and environmental regulations / legislation specific for the substance or mixture
This safety data sheet is in compliance with the following EU legislation and its adaptations - as far as applicable - : 67/548/EEC, 1999/45/EC, 98/24/EC,
92/85/EC, 94/33/EC, 91/689/EEC, 1999/13/EC, Commission Regulation (EU) 2015/830, Regulation (EC) No 1272/2008 and their amendments as well as
the following British legislation: - The Control of Substances Hazardous to Health Regulations (COSHH) 2002 - COSHH Essentials - The Management of
Health and Safety at Work Regulations 1999
ECHA SUMMARY
Ingredient CAS number Index No ECHA Dossier
subtilisins 9014-01-1 647-012-00-8 01-2119480434-38-XXXX
Acute Tox. 4, Skin Irrit. 2, Eye Dam. 1, Resp. Sens. 1, STOT SE 3, GHS09, GHS05, H302, H315, H334,
2
Aquatic Acute 1, Aquatic Chronic 2, Resp. Sens. 1B GHS08, Dgr H335, H318, H332
Harmonisation Code 1 = The most prevalent classification. Harmonisation Code 2 = The most severe classification.
Canada - DSL Y
Philippines - PICCS Y
USA - TSCA Y
CONTACT POINT
- For quotations contact your local Customer Services - http://wssdirectory.wilhelmsen.com/#/customerservices - - Responsible for safety data sheet
Wilhelmsen Ships Service AS - Prepared by: Product HSE Manager, - Email: Email: [email protected] - Telephone: Tel.: +31 10
4877775
Other information
Classification of the preparation and its individual components has drawn on official and authoritative sources as well as independent review by the
Chemwatch Classification committee using available literature references.
A list of reference resources used to assist the committee may be found at:
www.chemwatch.net
The SDS is a Hazard Communication tool and should be used to assist in the Risk Assessment. Many factors determine whether the reported Hazards are
Risks in the workplace or other settings.
For detailed advice on Personal Protective Equipment, refer to the following EU CEN Standards:
EN 166 Personal eye-protection
EN 340 Protective clothing
EN 374 Protective gloves against chemicals and micro-organisms
EN 13832 Footwear protecting against chemicals
EN 133 Respiratory protective devices